In late October, transnational companies such as BASF, Dow, and Bayer announced their third-quarter financial reports one after another. Against the background of the weak global economic recovery, the economic and trade markets in Europe and the United States have shrunk, and the economic growth in emerging countries has slowed down. The prices of global chemical products have generally declined, and sales and profits of many companies have been affected. However, in the face of adversity, we can still see the "bright spots" that have inspired the industry. BASF, Bayer and other companies continue to grow their business; specialty chemicals, new materials, etc. are sought after by the market; and companies responding to the crisis have adopted targeted reductions. The efficiency improvement measures have already been shown. In the face of the market outlook, these companies are confident that they expect a rise in the fourth quarter. "Volume drops or price drops" BASF, a leading chemical company in the world, experienced steady first-half sales. Sales in the third quarter increased by 8% year-on-year to EUR 19 billion, mainly due to sales. BASF Quarterly Report said that operating income (EBIT) excluding special items was approximately EUR 2.1 billion, a 5% increase from the same period last year; strong performance in the agricultural solutions, crude oil and natural gas operations offsets the chemicals business including chemicals, plastics, specialty products and features The decline in the revenue of the sexual solution business area. Bayer Group maintains continuous growth. Sales in the third quarter increased by 11.5% to 9.665 billion euros. The life science business and crop science business rose significantly. Material technology sales increased by 8.1% year-on-year to 2.992 billion euros. However, the company’s net income decreased compared to the same period of last year, and the pre-tax profit was 838 million euros, a decrease of 23.7%. Dow Chemical sales reached US$13.6 billion, adjusted sales fell 7%. The main reason for the decline came from Europe. Adjusted sales rose by 2%, and sales in all geographic regions increased, with growth coming from business sectors such as agricultural sciences, functional plastics, functional materials, and coatings and infrastructure solutions. Celanese’s sales for the third quarter were 1.609 billion U.S. dollars, compared to 1.807 billion U.S. dollars for the same period last year. Sales volume of the company's customer-oriented solution business increased year-on-year. However, due to lower prices of acetyl intermediates and special industrial products, this led to lower sales this quarter. The sales of special consumer goods amounted to US$314 million, a year-on-year increase of 5.4%, mainly due to the strong demand in the global market and the price increase of 6% year-on-year. Honeywell achieved 2% endogenous growth in the third quarter, mainly through the development of new products, the expansion of high-growth regions, and the growth of specialty products and electronic materials. These increases offset the company’s weakness in the European market; however, they were also dragged down by the downturn in the global end markets for fluorine products, resins and chemicals. "Exceptional measures" deal with difficulties Faced with numerous challenges, companies adopt active strategies and pragmatic measures, focusing on their own advantages and expanding their businesses while reducing costs and optimizing business processes. BASF constantly adjusts its business structure and will significantly increase its oil and gas production on the Norwegian continental shelf. Through the acquisition of Becker Underwood, it will become a leading supplier of biological seed treatment and biological crop protection technology. Dow accelerated its implementation of cost-reduction measures in the third quarter, and its effectiveness has been reflected in its operating results during the quarter. Focusing on the goals announced at the beginning of the year, the company implemented a streamlined operating model; adjusted financial plans, guaranteed cash flow, strictly controlled working capital and capital expenditures, especially in Europe; and strictly ordered growth projects in accordance with their priorities. Bayer MaterialScience actively expands its market with "innovative applications". Its polyurethane business grew by 10.2%, mainly due to the development of product lines, increased regional sales, and price growth factors; through the provision of downstream customer solutions, sales of the Coatings, Adhesives and Specialty Products business increased by 2.8%. Celanese's initiative is to launch its ethanol production technology development facility at its Ming Lake, Texas, production facility, provide TCX ethanol process technology to industrial ethanol and fuel ethanol customers, introduce new CelFX matrix technology for filter media, and stocks The repurchase authorization increased to 400 million U.S. dollars. Boost confidence in Jedi rebels The third quarterly report of multinational companies made a forecast for the market outlook. BASF adjusted its global economic forecast for 2012, in which the growth in the value of chemical production was adjusted from the previous 3.5% to 2.9%. Dr. Bokkai Ci, Chairman of BASF's Executive Board, said that the global economic outlook in the third quarter has not improved and the uncertainty in the international capital market still exists. It is expected that there will be no increase in global economic and chemical business demand in the fourth quarter. The company’s goal is to surpass the 2011 record sales and EBIT without special items. Dow Cheng, chairman and chief executive of Dow Chemical, said: “Dow is ready to enter into 2013. In order to reduce the impact of the global economic downturn, we will continue to implement the US$2.5 billion leverage measure established at the beginning of the year; It is committed to achieving the three goals of increasing the return on capital, increasing cash flow, and increasing revenue." The chairman of the Bayer Group Board of Directors, Dr. Dykes, confirmed the company's full-year sales and revenue forecasts announced in July this year. Dax said: "Money and asset portfolio adjusted sales in 2012 will increase by 4% to 5%, and sales will reach 39 to 40 billion euros." The chairman and CEO of Celanese’s Board of Directors, Romuke, said that it is expected that the challenging global economic environment will continue into 2013, taking into account seasonal factors, its adjusted earnings in the fourth quarter will be slightly higher than last year; the company will invest next year Technology innovation projects that can boost business growth are consistent with their long-term growth goals of 12% to 14%. Honeywell Chairman and Chief Executive Officer Goodwin said: "The next step will continue to be optimistic about investment in oil and gas and other areas." Wholesale Long Range Electric Motorcycle Racing Powerful Off Road Customized Electric Motorcycle Wuxi Jiangyin Xufeng Electric Bicycle Co., Ltd. , https://www.relxrides.com